{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:16:23Z","timestamp":1765808183749,"version":"3.40.5"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,23]]},"abstract":"<jats:p>Regimens for managing thromboembolic complications of COVID-19 are still not very well established. The present study compares the clinical characteristics and outcomes of patients hospitalized with COVID-19 receiving different anticoagulation regimens with and without aspirin. This is a retrospective observational study of 491 patients hospitalized for COVID-19 from August 2020 to April 2021. Data regarding clinical characteristics, laboratory findings, and outcomes of patients receiving different anticoagulation with and without aspirin regimens was collected, according to which 5 patient groups were defined: received no anticoagulation (NAA), prophylactic anticoagulation with (PA) or without aspirin (PAA) and therapeutic anticoagulation with (TA) or without aspirin (TAA). The average age was highest in the TAA group. Desaturation was highest in the TA and TAA groups. Diabetes, hypertension, dyslipidemia and coronary artery disease were the most prevalent in aspirin groups (PAA and TAA) as was heart failure in the TA and TAA groups and cancer in the TA and PAA groups. Elevated troponin was observed in the PAA and TAA groups. TA and TAA patients received oxygen therapy, needed ICU admission overall, and required invasive ventilation and vasopressors the most. Prophylactic anticoagulation groups (PA and PAA) had the highest patient survival rates. Patients with severe COVID-19 infections were more likely to receive higher, therapeutic, anticoagulation doses. Aspirin was given to patients with preexisting comorbidities, but it had no statistically significant impact on the outcomes of the different groups. Groups receiving prophylactic anticoagulation had the best survival outcomes.<\/jats:p>","DOI":"10.1097\/md.0000000000034040","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T17:33:27Z","timestamp":1687628007000},"page":"e34040","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effect of combination of prophylactic or therapeutic anticoagulation with aspirin on the outcomes of hospitalized COVID-19 patients: An observational retrospective study"],"prefix":"10.1097","volume":"102","author":[{"given":"Jonathan","family":"Mina","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Staten Island University Hospital, Staten Island, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Fleifel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Centre-Rizk Hospital, Beirut, Lebanon"},{"name":"Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Haykal","sequence":"additional","affiliation":[{"name":"Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Dimassi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Lebanese American University, Byblos, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janane","family":"Nasr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Centre-Rizk Hospital, Beirut, Lebanon"},{"name":"Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranime","family":"Harb","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Lebanese American University, Byblos, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Mahdi","sequence":"additional","affiliation":[{"name":"Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghida","family":"El Hout","sequence":"additional","affiliation":[{"name":"Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissar","family":"Franjieh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Centre-Rizk Hospital, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Mokhbat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Centre-Rizk Hospital, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Farra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Centre-Rizk Hospital, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6893-5027","authenticated-orcid":false,"given":"Rola","family":"Husni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Centre-Rizk Hospital, Beirut, Lebanon"},{"name":"Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0140-6736(21)02503-4","article-title":"Anticoagulation in COVID-19.","volume":"399","author":"Bradbury","year":"2022","journal-title":"Lancet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jmv.26346","article-title":"COVID-19 and coagulation dysfunction in adults: a systematic review and meta-analysis.","volume":"93","author":"Lin","year":"2021","journal-title":"J Med Virol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis.","volume":"29","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.medcli.2020.10.004","article-title":"[Mortality of covid-19 patients with vascular thrombotic complications].","volume":"156","author":"Gonzalez-Fajardo","year":"2021","journal-title":"Med Clin"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e2135397","DOI":"10.1001\/jamanetworkopen.2021.35397","article-title":"Factors associated with risk of postdischarge thrombosis in patients with COVID-19.","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e0861","DOI":"10.1002\/rcr2.861","article-title":"A case of massive saddle pulmonary embolism and benign tracheal stenosis in a patient with COVID-19 infection.","volume":"9","author":"Nehme","year":"2021","journal-title":"Respirol Case Rep"},{"key":"R9-20250504","first-page":"8875330","article-title":"Massive pulmonary embolism complicating coronavirus disease 2019 (COVID-19) pneumonia: a case report.","volume":"2020","author":"Hegde","year":"2020","journal-title":"Case Rep Crit Care"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with covid-19.","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","article-title":"Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial.","volume":"325","year":"2021","journal-title":"JAMA"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.","volume":"18","author":"Llitjos","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/jgid.jgid_180_20","article-title":"Persistent hypercoagulable state in COVID-19: a case series of COVID-19 associated pulmonary embolism.","volume":"13","author":"Chan","year":"2021","journal-title":"J Glob Infect Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ijlh.13547","article-title":"COVID-19\u2013related laboratory coagulation findings.","volume":"43","author":"Devreese","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"100883","DOI":"10.1016\/j.cegh.2021.100883","article-title":"The effects of aspirin on the outcome of COVID-19: a systematic review and meta-analysis.","volume":"12","author":"Wijaya","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e001628","DOI":"10.1136\/openhrt-2021-001628","article-title":"Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review.","volume":"8","author":"Matli","year":"2021","journal-title":"Open Heart"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002512-199506010-00004","article-title":"Anticoagulants in older patients.","volume":"6","author":"Beyth","year":"1995","journal-title":"Drugs Aging"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e0254066","DOI":"10.1371\/journal.pone.0254066","article-title":"Male gender is a predictor of higher mortality in hospitalized adults with COVID-19.","volume":"16","author":"Nguyen","year":"2021","journal-title":"PLoS One"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15537\/smj.2018.9.22630","article-title":"Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population.","volume":"39","author":"Elkhalifa","year":"2018","journal-title":"Saudi Med J"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5455\/jeos.20170113084303","article-title":"Effects of cigarette smoking on some coagulation parameters of smokers in Nnewi metropolis.","volume":"6","author":"Okeke","year":"2017","journal-title":"J Environ Occup Sci"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bmjebm-2020-111492","article-title":"Is there a smoker\u2019s paradox in COVID-19?","volume":"26","author":"Usman","year":"2021","journal-title":"BMJ Evid Based Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/ntr\/ntab004","article-title":"Impact of tobacco smoking on the risk of COVID-19: a large scale retrospective cohort study.","volume":"23","author":"Paleiron","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.32394\/pe.75.03","article-title":"The smoker\u2019s paradox during the COVID-19 pandemic? the influence of smoking and vaping on the incidence and course of SARS-CoV-2 virus infection as well as possibility of using nicotine in the treatment of COVID-19 - review of the literature.","volume":"75","author":"Korzeniowska","year":"2021","journal-title":"Przegl Epidemiol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/thoraxjnl-2021-217080","article-title":"Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.","volume":"77","author":"Clift","year":"2022","journal-title":"Thorax"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cpt196454428","article-title":"Effect of cigarette smoking on blood coagulation.","volume":"5","author":"Ambrus","year":"1964","journal-title":"Clin Pharm Therap"},{"key":"R32-20250504","first-page":"3566166","article-title":"Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis.","author":"Kumar","year":"2020","journal-title":"Soc Sci Res Netw"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"e001343","DOI":"10.1136\/bmjdrc-2020-001343","article-title":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.","volume":"8","author":"Yan","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/07853890.2021.1931957","article-title":"Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study.","volume":"53","author":"Zhong","year":"2021","journal-title":"Ann Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"711435","DOI":"10.3389\/fmed.2021.711435","article-title":"Longitudinal radiological findings in patients with COVID-19 with different severities: from onset to long-term follow-up after discharge.","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e4496488","DOI":"10.1155\/2021\/4496488","article-title":"Chest X-Ray findings in COVID-19 patients presenting to primary care during the peak of the first wave of the pandemic in Qatar: their association with clinical and laboratory findings.","volume":"2021","author":"Abougazia","year":"2021","journal-title":"Pulm Med"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"205873922110644","DOI":"10.1177\/20587392211064461","article-title":"Can chest radiographic findings determine disease severity in Covid-19-positive patients? a single-center study.","volume":"19","author":"Stevic","year":"2021","journal-title":"Eur J Inflamm"},{"key":"R40-20250504","first-page":"143","article-title":"Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis.","volume":"155","author":"Soraya","year":"2020","journal-title":"Med Clin (Engl Ed)"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40001-020-00432-3","article-title":"Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.","volume":"25","author":"Ghahramani","year":"2020","journal-title":"Eur J Med Res"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"398","DOI":"10.14740\/cr1159","article-title":"Cardiac Troponin-I and COVID-19: a prognostic tool for in-hospital mortality.","volume":"11","author":"Al Abbasi","year":"2020","journal-title":"Cardiol Res"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia.","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1177\/08971900211015055","article-title":"The impact of anticoagulation on COVID-19 (SARS CoV-2) patient outcomes: a systematic review.","volume":"35","author":"Lazaridis","year":"2021","journal-title":"J Pharm Pract"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"698935","DOI":"10.3389\/fmed.2021.698935","article-title":"Effect of anticoagulant administration on the mortality of hospitalized patients with COVID-19: an updated systematic review and meta-analysis.","volume":"8","author":"Jiang","year":"2021","journal-title":"Front Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:02:41Z","timestamp":1746324161000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":41,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034040","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,6,23]]}}}